Invitrogen, the San Diego-based maker of lab products, said it plans to change its name to Life Technologies when it completes the acquisition of Foster City, CA-based Applied Biosystems. The new company will trade on the NASDAQ exchange under the ticker “LIFE.” Instruments will continue to be sold under the Applied Biosystems brand name, while chemical reagents will still be sold under the Invitrogen name, the company said. The merger is awaiting approval from European regulators.
Author: Luke Timmerman
Luke is an award-winning journalist specializing in life sciences. He has served as national biotechnology editor for Xconomy and national biotechnology reporter for Bloomberg News. Luke got started covering life sciences at The Seattle Times, where he was the lead reporter on an investigation of doctors who leaked confidential information about clinical trials to investors. The story won the Scripps Howard National Journalism Award and several other national prizes. Luke holds a bachelor’s degree in journalism from the University of Wisconsin-Madison, and during the 2005-2006 academic year, he was a Knight Science Journalism Fellow at MIT.
View all posts by Luke Timmerman
